IMS
Chinese government to lift drug price controls
May 5, 2015Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government
The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …
Global drug spending set to top $1 trillion
November 20, 2014Sales and Marketing Gilead, IMS, Kadcyla, Perjeta, drugs, hepatitis C, sovaldi, spend
Worldwide spending on drugs will reach over $1 trillion in 2014 and $1.3 trillion by 2018, according to a new …
Global cancer drug spend slows
May 7, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, IMS, spending
Spending on cancer drugs worldwide is slowing, according to a new report from the IMS Institute for Healthcare Informatics. The …
Pharma must use cloud-based tech, says report
March 13, 2014Medical Communications, Sales and Marketing IMS, cloud, digital, pharma, technology
Cloud-based technologies are the way forward for the pharma sector as global budget pressures continue to bite – that is …
German law could see pharma discounts published
February 18, 2014Sales and Marketing AMNOG, Germany, IMS, NICE, prices
Pharma companies are apprehensive about German lawmakers opening Pandora’s Box this week if they go ahead with plans to publish …
J&J: we’re proud to top social media leaderboard
January 27, 2014Medical Communications, Sales and Marketing IMS, J&J, JJ, Janssen, digital, epatient, pharma
Johnson & Johnson says recognising the rise of the ePatient and being willing to share its corporate plans with the …
J&J tops social media leaderboard
January 22, 2014Medical Communications, Research and Development, Sales and Marketing Facebook, IMS, J&J, JJ, Twitter, You Tube, social media
A new report has found that Johnson & Johnson is the most engaged pharma company when it comes to using …
Global prescriptions cost to hit $1 trillion
November 20, 2013Medical Communications, Research and Development, Sales and Marketing IMS, UK, prescriptions
The worldwide cost of medicine prescriptions will for the first time hit $1 trillion next year as drugs get more …
NICE medicines uptake dissected
November 23, 2012Sales and Marketing HSCIC, IMS, NICE
Lack of diagnosis, ignoring required tests, muddled commissioning and local policy variations are among the key reasons why NICE-approved drugs …
Huge increase in emerging market spending to lift pharma
July 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, IMS, emerging markets, pharmerging
The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …
Generics push US drug growth to $307bn
April 20, 2011IMS, IMS Health, drug spending, healthcare spending
Generics replaced branded drugs as the main growth drivers for the US pharmaceutical market in 2010. The market saw just …
Pharma sector growth to improve in 2011
November 19, 2010Sales and Marketing 2011, IMS, IMS Health, forecast, growth, pharma
2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …
IMS promotes Adel Al-Saleh to senior sales role
July 26, 2010Sales and Marketing IMS, appointment, sales and marketing
IMS Health has promoted Adel Al-Saleh to the newly created position of senior vice president, sales and global account management. …
Emerging markets and generics poised to drive pharma growth
April 20, 2010Sales and Marketing IMS, em, emerging markets
The global pharma market will reach $1.1 trillion in 2014 through growth primarily driven by emerging markets and generics, according …
IMS adds countries to ‘pharmerging’ hit-list
March 18, 2010Sales and Marketing China, IMS, em
IMS Health has added 10 more countries to its list of ‘pharmerging markets’ which represent the future of pharma industry …
Latest content
FibroFind appoints Lee Borthwick as CEO
